Competition may heat up soon in the developing ultrasound bone densitometry market. Bone densitometry vendor Norland has acquired rights to distribute worldwide all existing and future ultrasound bone measurement systems developed by Canadian vendor
Competition may heat up soon in the developing ultrasound bone densitometry market. Bone densitometry vendor Norland has acquired rights to distribute worldwide all existing and future ultrasound bone measurement systems developed by Canadian vendor IMRO.
The device developed by IMRO provides ultrasound bone measurement at the heel and will be sold by Norland as Paris. The bone department of McGill University in Toronto has selected the IMRO device to be used exclusively in an ongoing clinical study, according to White Plains, NY-based Norland.
Norland expects to begin marketing Paris shortly in Europe, Latin America, and the Pacific Rim, and an application for Food and Drug Administration 510(k) clearance should be filed by the end of the year, according to the company.
In other Norland news, shareholders have approved its acquisition of Norland Corp., the Ft. Atkinson, WI-based company that manufactures the DEXA (dual-energy x-ray absorptiometry) scanners that Norland distributes (SCAN 3/19/97).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.